(Q62110729)

English

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma (English)

0 references

0 references

0 references

Jonsson Comprehensive Cancer Center

0 references

country

United States of America

0 references

start time

June 2004

0 references

end time

January 2013

0 references

number of participants

30

0 references

research intervention

bortezomib

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00084747

0 references

(Q62110729)

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)